-
Gramine for Ferroptosis and TNBC Research
2026-08-27
Gramine is a mechanism-oriented tool for linking ferroptotic cell death with the CUL3–MTDH ubiquitination axis in triple-negative breast cancer models. This workflow translates reported target-validation findings into practical dose-response, rescue, biomarker, and troubleshooting strategies for cancer biology research.
-
NETosis and IL-36R Signaling in Psoriasis
2026-08-27
The reference study identifies coordinated TLR3 and P2X7R stimulation as a driver of neutrophil extracellular trap formation and links NET-associated inflammation to amplification through the IL-36/IL-36R axis. Its combination of ligand-based neutrophil experiments, an imiquimod-induced mouse model, primary keratinocytes, and Il1rl2 deficiency provides a mechanistic framework for studying NETosis as a modifiable component of psoriatic inflammation.
-
Iptacopan (LNP023) Complement Research Workflows
2026-08-26
Build more interpretable complement activation research with Iptacopan (LNP023), from factor B target engagement to C3 deposition and membrane attack complex readouts. This workflow guide connects complement-mediated hemolysis assays with translational disease models while emphasizing matrix control, orthogonal endpoints, and practical troubleshooting.
-
Nadolol (SQ-11725) Research Workflows
2026-08-26
Build cleaner cardiovascular experiments with Nadolol (SQ-11725), from beta-adrenergic pathway perturbation to transporter-aware exposure checks. This guide combines practical assay setup, comparative use cases, and lessons from a recent pharmacokinetic study without overstating cross-disease evidence.
-
Lisinopril Dihydrate: An Assay-First Guide
2026-08-25
Lisinopril dihydrate is a long-acting ACE inhibitor for mechanistic cardiovascular and renal research. This assay-first guide connects its renin–angiotensin system activity with peptidase counter-screening, formulation control, and model-specific interpretation.
-
Fingolimod (FTY720): Mechanism and Research Use
2026-08-25
Fingolimod (FTY720) is an orally bioavailable sphingosine-1-phosphate receptor modulator used clinically for relapsing multiple sclerosis. Its best-established action is lymphocyte egress inhibition, while BDNF and ERK1/2 findings support separate neurobiological research applications.
-
Gramine–CUL3–MTDH Ferroptosis in TNBC
2026-08-24
A 2026 reference study identifies Gramine as a mechanistically supported ferroptosis inducer in triple-negative breast cancer, acting through CUL3-mediated control of MTDH stability. Its combination of chemical-proteomic screening, target-engagement assays, genetic rescue, and mouse-model validation provides a framework for studying MTDH ubiquitination in cancer biology research.
-
Mucocutaneous Candidiasis: Diagnosis and Treatment
2026-08-24
This 2009 clinical review integrates lesion classification, direct microscopy, risk-factor assessment, and treatment selection for cutaneous and oral candidiasis. Its most practical contribution is a diagnostic-and-management framework that distinguishes colonization from disease and links recurrence prevention to correction of local and systemic susceptibility factors.
-
Hyaluronic acid sodium salt for Reliable Assays
2026-08-23
Learn how Hyaluronic acid sodium salt (SKU B8382) can be integrated into cell viability, proliferation, cytotoxicity, extracellular matrix, and nanoparticle workflows. This scenario-driven guide emphasizes assay controls, material handling, interpretation, and practical vendor-selection criteria.
-
From lncRNA Mechanisms to Translational RT-qPCR
2026-08-22
A mechanistic and strategic guide to translating the PART1/miR-503-5p/FOXK1 ovarian cancer model into more reliable gene-expression workflows, with practical guidance on primer choice, complex RNA templates, controls, and the role of the HyperScript™ First-Strand cDNA Synthesis Kit.
-
FITC-Concanavalin A (ConA) Conjugate Guide
2026-08-22
FITC-Concanavalin A (ConA) Conjugate provides direct fluorescent detection of accessible α-D-glucose and α-D-mannose residues on cells and tissue sections. It is intended for carbohydrate-focused immunofluorescence staining, microscopy, and flow cytometry workflows, not for identifying non-carbohydrate targets or unvalidated assay formats.
-
RQ3025 Broad-Spectrum Bivalent mRNA Vaccine Study
2026-08-21
The reference study evaluates RQ3025, a bivalent mRNA vaccine designed around recurrent SARS-CoV-2 spike mutations, across several animal models. Its broad neutralizing activity, variant protection, Th1-biased cellular response, and favorable histological profile support further development while remaining strictly preclinical evidence.
-
Cyclic di-GMP, HipH, and Biofilm Persistence
2026-08-20
The 2024 eLife study identifies Cyclic di-GMP as a small-molecule antitoxin that restrains the genotoxic toxin HipH during biofilm development. Its findings connect adhesion-stage signaling with DNA double-strand breaks, genome instability, and antibiotic persistence, providing a mechanistic framework for studying biofilm resilience beyond simple diffusion or nutrient-limitation models.
-
BMP4-GPX4 Protects RGCs in NMDA Glaucoma Models
2026-08-20
Fang et al. identify a BMP4-GPX4 response associated with reduced ferroptotic stress and improved retinal stem cell differentiation after transplantation in an NMDA-induced high-intraocular-pressure glaucoma model. The work connects RGC preservation, iron-dependent oxidative injury, and regenerative cell therapy, while providing a multi-readout framework for studying retinal neurodegeneration.
-
Isorhamnetin Activates PI3K/Akt in Oocyte Maturation
2026-08-19
The reference study shows that isorhamnetin improves porcine oocyte maturation by reducing oxidative, mitochondrial, apoptotic, and endoplasmic reticulum stress while activating PI3K/Akt signaling. Its integrated design connects polar body extrusion with molecular stress readouts, providing a useful framework for oxidative stress research while leaving human fertility translation unresolved.